Revenio Group Oyj (LON:0KFH)

Market Cap	583.60M
Revenue (ttm)	85.84M
Net Income (ttm)	15.30M
Shares Out	n/a
EPS (ttm)	0.57
PE Ratio	38.15
Forward PE	n/a
Dividend	0.33 (1.20%)
Ex-Dividend Date	Apr 5, 2024

Volume	264
Average Volume	5,883
Open	27.86
Previous Close	27.81
Day's Range	27.16 - 27.86
52-Week Range	17.59 - 41.32
Beta	1.38
RSI	38.57
Earnings Date	Feb 13, 2025

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, ...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2001
• Employees: 241
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KFH

Financial Performance

In 2024, Revenio Group Oyj's revenue was 103.80 million, an increase of 7.25% compared to the previous year's 96.79 million. Earnings were 18.50 million, a decrease of -3.19%.

Financial numbers in EUR